| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 药品流通业(元) | 169,307,648.13 | 858,767,362.89 | 627,362,706.64 | 1,436,887,050.29 | 675,461,749.49 |
| 药品制造业及其他(元) | 277,803,142.44 | 623,604,382.32 | 329,946,699.52 | 623,127,592.36 | 332,666,458.61 |
| 营业成本(元) | |||||
| 药品流通业(元) | 154,269,014.93 | 758,957,153.04 | 551,850,466.32 | 1,243,238,871.17 | 585,666,886.68 |
| 药品制造业及其他(元) | 133,524,016.25 | 307,856,464.63 | 158,205,125.90 | 264,302,042.87 | 131,180,517.28 |
| 毛利(元) | |||||
| 药品流通业(元) | 15,038,633.20 | 99,810,209.85 | 75,512,240.32 | 193,648,179.12 | 89,794,862.81 |
| 药品制造业及其他(元) | 144,279,126.19 | 315,747,917.69 | 171,741,573.62 | 358,825,549.49 | 201,485,941.33 |
| 毛利率(%) | |||||
| 药品流通业(%) | 8.88 | 11.62 | 12.04 | 13.48 | 13.29 |
| 药品制造业及其他(%) | 51.94 | 50.63 | 52.05 | 57.58 | 60.57 |
| 收入构成(%) | |||||
| 药品流通业(%) | 37.87 | 57.93 | 65.53 | 69.75 | 67.00 |
| 药品制造业及其他(%) | 62.13 | 42.07 | 34.47 | 30.25 | 33.00 |
| 毛利构成(%) | |||||
| 药品流通业(%) | 9.44 | 24.02 | 30.54 | 35.05 | 30.83 |
| 药品制造业及其他(%) | 90.56 | 75.98 | 69.46 | 64.95 | 69.17 |